← Back to Clinical Trials
Recruiting NCT06234501
Testing the Efficacy of 100mg Vitamin-B6 Daily for Sensory Reactivity in Autism
Trial Parameters
Condition Autism
Sponsor University of Reading
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 18 Years
Max Age 60 Years
Start Date 2024-11-08
Completion 2026-07
Interventions
Pyridoxal 5'-Phosphate (100 mg)Placebo
Brief Summary
This clinical trial aims to explore the effect of Vitamin B6 supplementation on anxiety sensory hyperreactivity in autistic adults. Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6 reduce anxiety and sensory reactivity differences in autism.
Eligibility Criteria
Inclusion Criteria: * Between the ages of 18 to 60 * With a diagnosis of autism Exclusion Criteria: * Taking any supplement that contains more than 2mg of Vitamin B6 or taking GABA agonist drugs * Have a medical history of peripheral neuropathy * lactose intolerance (placebo tablet is lactose based)